PGRMC2 and endometrial endometrioid carcinoma: Through the use of a well-established mouse model of Pten loss-of-function-induced endometrioid endometrial carcinoma, this study demonstrates that the loss of Pgrmc2 attenuates endometrial hyperplasia and cancer incidence and severity, in part, by inhibiting endometrial glandular epithelial cell proliferation.